# AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs

> **NCT00846911** · — · COMPLETED · sponsor: **Bayer** · enrollment: 2672 (actual)

## Conditions studied

- Bronchitis, Chronic

## Interventions

- **DRUG:** Moxifloxacin (Avelox, BAY12-8039)

## Key facts

- **NCT ID:** NCT00846911
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 2672 (ACTUAL)
- **Last updated:** 2012-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00846911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00846911, "AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00846911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*